BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23793761)

  • 1. The role of methylation in urological tumours.
    van der Heijden AG
    Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cytogenetic events in urologic tumors.
    Klein EA; Fair WR; Chaganti RS
    Semin Urol; 1988 Feb; 6(1):2-21. PubMed ID: 2838875
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour suppressor genes in urinary tract oncology.
    Brewster SF; Gingell JC; Brown KW
    Br J Urol; 1992 Dec; 70(6):585-90. PubMed ID: 1336697
    [No Abstract]   [Full Text] [Related]  

  • 5. [Optimizing treatment of advanced urologic malignancies].
    Heidenreich A; Ohlmann CH; Ozgür E; Pfister D; Sahi D; Thüer D; Engelmann UH
    Urologe A; 2007 Sep; 46(9):1278-84. PubMed ID: 17628781
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylation profile of DNA repetitive elements in human testicular germ cell tumor.
    Ushida H; Kawakami T; Minami K; Chano T; Okabe H; Okada Y; Okamoto K
    Mol Carcinog; 2012 Sep; 51(9):711-22. PubMed ID: 21809391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in urological malignancies (review).
    Schulz WA
    Int J Oncol; 1998 Jul; 13(1):151-67. PubMed ID: 9625817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
    Netto GJ
    Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epigenome of testicular germ cell tumors.
    Lind GE; Skotheim RI; Lothe RA
    APMIS; 2007 Oct; 115(10):1147-60. PubMed ID: 18042148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epigenetic regulation of urological tumors. Importance for prognosis and metastasis].
    Heinzelmann J; Stubendorff B; Jung V; Baumgart S; Hölters S; Unteregger G; Grimm J; Linxweiler J; Janssen M; Ohlmann CH; Saar M; Siemer S; Stöckle M; Junker K
    Urologe A; 2015 Jun; 54(6):832-8. PubMed ID: 26037021
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).
    Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA
    J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas.
    Florl AR; Löwer R; Schmitz-Dräger BJ; Schulz WA
    Br J Cancer; 1999 Jul; 80(9):1312-21. PubMed ID: 10424731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
    Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
    Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic biomarkers in the blood of patients with urological malignancies.
    Ellinger J; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
    Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of gene therapy in the treatment of urological tumors].
    Heidenreich A; von Knobloch R; Hofmann R
    Urologe A; 1999 Nov; 38(6):603-13. PubMed ID: 10591808
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigenetics and testicular germ cell tumors.
    Buljubašić R; Buljubašić M; Bojanac AK; Ulamec M; Vlahović M; Ježek D; Bulić-Jakuš F; Sinčić N
    Gene; 2018 Jun; 661():22-33. PubMed ID: 29605605
    [No Abstract]   [Full Text] [Related]  

  • 20. Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
    Morris MR; Hesson LB; Wagner KJ; Morgan NV; Astuti D; Lees RD; Cooper WN; Lee J; Gentle D; Macdonald F; Kishida T; Grundy R; Yao M; Latif F; Maher ER
    Oncogene; 2003 Oct; 22(43):6794-801. PubMed ID: 14555992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.